Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(13%)
Results Posted
25%(1 trials)

Phase Distribution

Ph not_applicable
6
75%
Ph phase_4
2
25%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution8 total trials
Phase 4Post-market surveillance
2(25.0%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(4)
Other(3)

Detailed Status

Completed4
unknown3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (25.0%)
N/A6 (75.0%)

Trials by Status

completed450%
unknown338%
recruiting113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DEVICE
Total Trials
8